Project Grant R01DA061766
Award Date
4/1/25
Completion Date
1/31/30
Dollars Obligated
$428K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Birmingham, AL 35294, USA
Similar Awards
This Project Grant award, totaling $1,076,036, was made by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The project aims to characterize electroencephalography (EEG) signatures related to the function of specific inhibitory neuron subtypes in the prefrontal cortex (PFC) and how they are altered by chronic opioid use. The University of Pittsburgh will lead this research, which seeks to improve understanding of how PFC circuit...
This $284,040 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support research to map molecular changes associated with chronic opioid exposure in specific cell populations and projections within the habenula (HB) brain region. The Lieber Institute for Brain Development, a non-profit medical research institute, will lead this 2-year project using integrated single-cell and spatial transcriptomic...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $159,711 to the University of California, Los Angeles (UCLA) to conduct research on the electrophysiological dynamics of acute opioid use in human reward, affect, and pain pathways.
The key objectives of this 5-year research project are to: 1) assess changes in reward and affect network connectivity during acute opioid administration, 2)...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) is providing $149,284 to the University of Washington to investigate the role of subpopulations of prefrontal cortex pyramidal neurons in regulating drug-seeking behavior. The research aims to use combinatorial viral approaches, fiber photometry, and chemogenetic techniques to characterize alterations to intratelencephalic (IT) and pyramidal tract (PT)...
This $173,167 Project Grant was awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant supports research to investigate the role of hypothalamic GABA and glutamate signaling in mediating motivation for opioid reward. The key objectives are to determine the causal behavioral function of lateral hypothalamus subpopulations during opioid motivation, and to characterize the relationship between signaling dynamics in these...
This $373,181 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under CFDA Program 93.279 "Drug Use and Addiction Research Programs" will fund research at Miami University to investigate the role of cholinergic interneurons in regulating opioid-related behaviors.
The key objectives are to determine 1) whether mu-opioid receptors on cholinergic interneurons contribute to opioid reward and withdrawal, and 2) whether these receptors regulate dopamine release during...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $562,014 in funding to the University of California, San Diego (UCSD) over a period of 5 years from September 2024 to July 2029. The purpose of this grant is to conduct research on the role of the medial habenula (MHB) and interpeduncular nucleus (IPN) neural circuit in opioid dependence and withdrawal. The research aims to identify the...
This $858,600 federal Project Grant award was provided by the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Pittsburgh. The goal of this 5-year project is to identify and validate G protein-coupled receptors (GPCRs) expressed by prefrontal cortex somatostatin-expressing inhibitory neurons that could be targeted for the development of new treatments for opioid use disorder (OUD). The researchers will use an unbiased...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), part of the Drug Use and Addiction Research Programs (CFDA 93.279), provides $751,043 to investigate the mechanisms underlying the co-occurrence of opioid use disorder (OUD), major depressive disorder (MDD), and HIV in the human brain.
The University of Massachusetts Medical School is the prime awardee and will use single-nucleus RNA sequencing and single-nucleus chromatin accessibility sequencing to examine...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $159,362 to the University of Miami for a research project titled "The Role of Parabrachial CGRP Neurons in Opioid Reinforcement."
The objective of this 4-year project is to assess the functional role of calcitonin gene-related peptide (CGRP)-expressing neurons in the parabrachial nucleus (CGRPPBN) in opioid reinforcement and...